// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Quality assurance of full polysomnography scoring using the American Academy of Sleep Medicine (AASM) inter-scorer reliability (ISR) program

Adrian Hugh Kendrick - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Outpatient initiation of long term domiciliary non-invasive ventilation in chronic stable type II respiratory failure

Richard Glover - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Visual analogue scores for interstitial lung disease: a prospective validation study

Helen Yates - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Measurement of lung distensibility in healthy children

Nidhal Gharbawi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Training in Multiple Breath Washout (MBW) testing for bronchiectasis (BE) clinical trials

Katherine O'Neill - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care

Biswajit Chakrabarti - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dry powder inhaled ribavirin in healthy volunteers: safety, tolerability, lung and systemic pharmacokinetics

Julia Billiard - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Ribavirin

The effect of gender on sputum microbiological profile in non-cystic fibrosis bronchiectasis

Kai Lee - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Five year Cohort Analysis of Non-Tuberculosis Mycobacterium Lung Disease at a Tertiary Referral Centre

Rudy Sinha-Ray - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Tuberculosis

N/A

Neutrophil extracellular trap formation in peripheral blood and airway neutrophils in bronchiectasis and CF

Holly Rachael Keir - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin-reversed arterial perfusion

N/A

Bronchospasm secondary to nebulised antibiotics in bronchiectasis

Raymond Njafuh - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Chest physiotherapy in European patients with bronchiectasis: Data from the EMBARC registry

Beatriz Herrero Cortina - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Non-tuberculous mycobacteria – number of drugs and duration of treatment – does it matter?

Javed Ibrahim - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

RSV infection of the airway epithelial cell line BEAS-2B stimulate NK cells

Jennifer Davies - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon Gamma

Transcriptomic analyses reveal anti-viral responses of epithelial cells and multiple immune cell types in HRV infected human lung tissue

Helena Obernolte - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Interferon

The response of macrophages to Moraxella catarrhalis infection

Jodie Ackland - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

IFN-lambda

Effect of corticosteroids on innate and adaptive T cell responses to non-typeable Haemophilus influenzae

Joshua Wallington - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Fluticasone propionate

Is the CURB65 score fit for purpose - a retrospective analysis

Davinder Dosanjh - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exposure to particulate matter increases pyocyanin production in Pseudomonas aeruginosa

Lisa Miyashita - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cigarette smoke redirects Staphylococcus aureus to a virulence phenotype associated with persistent infection

Maisem Laabei - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

DE-074

Copyright © 2026. QuantiNova All rights reserved